Taiwan FDA registration 9353de8d0ad5abac783e86af51cc6830
Metías spirezia pallidum antibody latex agglutination reagent
TW: 美帝亞斯梅毒螺旋菌抗體乳膠凝集試劑
Taiwan·Risk Class 2·SEKISUI MEDICAL CO., LTD. TSUKUBA PLANT·Registered Oct 18, 2010 – Oct 18, 2025ExpiredRegistration details
- Analysis ID
- 9353de8d0ad5abac783e86af51cc6830
- Customs Code
- DHA00602166200
Company information
- Manufacturer
- SEKISUI MEDICAL CO., LTD. TSUKUBA PLANT
- Manufacturer Country
- Japan
- Authorized Representative
- KUO'S YUAN IN ENTERPRISE CO., LTD.
Product details
- Intended Use
- Antispirochelina pallidum antibodies are measured by latex agglutination in serum or plasma.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.3830 Treponema pallidum test
- Import Information
- import
Dates and status
- Registration Date
- Oct 18, 2010
- Expiry Date
- Oct 18, 2025
About this record
Access comprehensive regulatory information for Metías spirezia pallidum antibody latex agglutination reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 9353de8d0ad5abac783e86af51cc6830 and manufactured by SEKISUI MEDICAL CO., LTD. TSUKUBA PLANT. The authorized representative in Taiwan is KUO'S YUAN IN ENTERPRISE CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices